Your session is about to expire
← Back to Search
Merotocin for Premature Birth (MERMAID Trial)
MERMAID Trial Summary
This trial looks at whether a drug can help women with preterm babies and low milk production to make more milk.
- Premature Birth
- Low Milk Supply
MERMAID Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMERMAID Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MERMAID Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
For this research, are only adults above a certain age being asked to participate?
"Eligible patients for this study must be 18 years old or older, but younger than 44."
How many total participants are allowed in this clinical trial?
"The trial, which is being conducted by Ferring Pharmaceuticals, needs to recruit 100 eligible patients from various locations including Houston, Texas and Charleston, South carolina."
Are there any unfilled positions for participants in this experiment?
"Yes, the trial is still recruiting patients. Originally posted on May 28th, 2021 and edited as recently as November 10th, 2022, this study has 100 enrollees with 19 different sites."
Have other research groups conducted similar investigations before?
"Merotocin has been under scientific scrutiny since 2021 when the first clinical trial, sponsored by Ferring Pharmaceuticals, was completed. A Phase 2 study involving 100 patients allowed Merotocin to skip to drug approval stage. As of now, only one active trial is being conducted and funded by Ferring Pharmaceuticals."
How many locations are currently conducting this trial?
"Yale School of Medicine in Houston, Cincinnati Children's Hospital Medical Center in Charleston, and Wake Medical Center in Cincinnati are three of the nineteen available locations for this clinical trial."
Are there any recorded dangers of Merotocin?
"While there is some evidence of Merotocin's safety, it has not been proven effective yet and thus received a score of 2."
Has Merotocin been used in previous research studies?
"Merotocin was first studied in 2021 at the Ferring Investigational Site. Including that original study, there have been a total of 18290 completed clinical trials as of now. Additionally, there is 1 actively recruiting trial presently, with a number of locations throughout Houston, Texas."
Who would be an ideal candidate to help with this medical research?
"This trial is accepting 100 people with inadequate milk production aged 18 and 44. Most importantly, applicants should meet the following criteria: Delivered at the hospital system associated with the trial center, Delivered preterm singleton gestational age 24 weeks + 0 days to 34 weeks + 2 days, Willing to express milk at least 5 times every 24 hours during the observation period and 6 to 8 times every 24 hours during the treatment and post-treatment follow up, Produced < 200 mL milk in 24 hours prior to randomization, Delivered 96 to 192 (+4) hours prior to randomization."
Share this study with friends
Copy Link
Messenger